Allopregnanolone Alters the Gene Expression Profile of Human Glioblastoma Cells

    Carmen J. Zamora-Sánchez, Aylin Del Moral-Morales, Ana M. Hernández-Vega, Valeria Hansberg-Pastor, Iván Salido-Guadarrama, Mauricio Rodríguez-Dorantes, Ignacio Camacho‐Arroyo
    TLDR Allopregnanolone changes gene expression in glioblastoma cells.
    The study investigated the effects of allopregnanolone (3α-THP), progesterone (P4), and finasteride (F) on gene expression in U87 human glioblastoma cells, revealing that 3α-THP significantly altered 137 genes, F changed 90, and P4 modified only six. Both 3α-THP and F up-regulated genes involved in DNA integrity, replication, and cytoskeleton reorganization. The study validated changes in 10 selected genes, with 3α-THP up-regulating six. Combined treatments showed distinct gene expression changes, suggesting F modulates the effects of P4 and 3α-THP. The findings highlighted the potential of 3α-THP and F in influencing glioblastoma cell behavior and suggested further research to explore their clinical applications.
    Discuss this study in the Community →

    Cited in this study

    5 / 5 results